Results 231 to 240 of about 24,082,158 (296)
Investing in the Next Generation: How the CDC John R. Lewis Undergraduate Public Health Scholars Program Is Transforming the US Public Health Workforce. [PDF]
Lichtveld M +9 more
europepmc +1 more source
ABSTRACT Objective Amyotrophic lateral sclerosis (ALS) is a clinically heterogeneous neurodegenerative disease requiring reliable biomarkers to improve patient stratification and trial design. While serum neurofilament light chain (sNfL) reflects neuroaxonal stress and disease aggressiveness, troponin T (TnT) may capture complementary aspects of ...
Julia Sellin +8 more
wiley +1 more source
Limitations in US Cancer Screening Rate Data and Opportunities to Improve Precision Prevention. [PDF]
Hoyos J +6 more
europepmc +1 more source
ABSTRACT Objective Progression independent of relapse activity is a major determinant of long‐term disability in multiple sclerosis, but its immunopathologic basis remains incompletely understood. We investigated whether relapse‐independent progression in radiologically stable relapsing–remitting multiple sclerosis is associated with distinct ...
Antonio Bruno +19 more
wiley +1 more source
Underfunded and undervalued: community-based health promotion practitioners' experiences of Western Australia's prevention sector. [PDF]
Wallace R, Costello L, Cook EJ.
europepmc +1 more source
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a devastating neurological disease that lacks serological biomarkers that can accurately reflect disease activity. We established a live cell‐based assay (LCBA) using serum with endogenous complement to quantify the overall cytotoxicity, offering a novel functional tool for monitoring
Xiaona Xu +10 more
wiley +1 more source
Medical Societies in the United States: History, Purpose, Challenge, and Future Directions. [PDF]
Schiller G, Leer LR.
europepmc +1 more source
Cancer Incidence, Healthcare Access, and Support Resource Distribution in Delaware : A Statewide Epidemiological Analysis, 2018-2022. [PDF]
Stephens R, Smith K.
europepmc +1 more source

